Energy & Materials Innovation
American Resources Corporation (NASDAQ: AREC) has doubled the daily production of high-purity rare earth oxides at its Noblesville facility as part of a rapid Phase 2 expansion. This boost underscores its unique modular refining platform – the only U.S.-based scalable solution for both heavy and light rare earth elements – positioning the company to meet surging domestic demand amid evolving global trade policies. Read the full announcement.
National Energy Services Reunited Corp. (NESR) has broken ground on a 180,000m² state-of-the-art facility at King Salman Energy Park in Saudi Arabia. Incorporating AI for drilling optimization, the project supports Saudi Arabia’s Vision 2030 and signals a shift in regional oilfield services. See more in the coverage.
Chevron (NYSE: CVX) has commenced oil and natural gas production at its Ballymore subsea tieback project in the deepwater Gulf of America, targeting up to 75,000 gross barrels of oil per day through three wells. Details are available in the release.
TotalEnergies announced first oil production at the deepwater Ballymore field offshore the U.S. With a 40% stake alongside Chevron’s 60%, the project is set to deliver a net contribution of nearly 30,000 boe/d and boost deepwater output to over 75,000 boe/d. Read more in the announcement.
Tech & Digital Innovation
Hesai Group (NASDAQ: HSAI) has unveiled its new Infinity Eye lidar solution for autonomous driving systems. Designed for L2 to L4 applications and integrating next-generation products like the ETX ultra-long-range lidar, the system marks an important step in advancing autonomous technology. Discover further details in the update.
Flux Power Holdings (NASDAQ: FLUX) launched its new G96-G2 High Voltage lithium-ion energy solution for ground support equipment, securing its first order from a major airline customer. Engineered for heavy-duty performance with integrated heaters and advanced battery management, full details are in the announcement.
Healthcare & Biotech Advances
Coya Therapeutics (NASDAQ: COYA) has published research for its COYA 303 biologic—a novel combination of low‐dose interleukin 2 and a GLP-1 receptor agonist—that achieved a 42% increase in regulatory T cell suppressive function. The study, conducted at Houston Methodist Research Institute, points to a differentiated approach for autoimmune and neurodegenerative treatments. Read the publication.
Achieve Life Sciences (NASDAQ: ACHV) announced the complete Phase 3 ORCA-3 trial results for cytisinicline in smoking cessation, published in JAMA Internal Medicine. The study involving 792 U.S. adults showed significant improvements in quit rates and reduced nicotine cravings, paving the way for an NDA submission to the FDA in June 2025. See the results.
Myriad Genetics (NASDAQ: MYGN) announced that a study on its GeneSight® Psychotropic Test revealed nearly a 40% reduction in prescriptions with significant gene-drug interactions and a 39% reduction in psychiatric hospitalizations among major depressive disorder patients. Full study details are in the announcement.
NeuroNOS, a subsidiary of Beyond Air (NASDAQ: XAIR), has secured FDA Orphan Drug Designation for BA-102, its lead investigational therapy targeting Phelan-McDermid Syndrome—a rare neurodevelopmental disorder linked to autism. The designation offers benefits including market exclusivity and tax credits, with first-in-human trials planned for 2026. Read more in the announcement.
Veracyte (VCYT) announced that its Decipher Prostate Genomic Classifier data is now integrated into the National Cancer Institute’s SEER specialized database. Covering over 560,000 prostate cancer cases, this linkage will help correlate genomic profiles with real-world outcomes and enhance research efforts. More information is available in the release.
Corporate Governance & Communications
Phillips 66 (NYSE: PSX) has issued a pivotal letter to shareholders ahead of its May 21, 2025 Annual Meeting amid a proxy contest with activist Elliott. Highlighting a record of returning $43 billion to shareholders, the letter outlines the company’s strategy to defend its board proposals. Read the complete statement.
Upexi (NASDAQ: UPXI) successfully priced a $100 million private placement by issuing 43,859,649 common shares at $2.28 per share, led by Alliance Global Partners. The financing underscores strong crypto venture capital interest. More details are in the announcement.
Pacira BioSciences (NASDAQ: PCRX) announced a landmark $300 million share repurchase program supported by DOMA Perpetual Capital Management, aiming to boost pre-tax margins and return capital to shareholders. Read the full announcement.
Mergers, Acquisitions & Strategic Transactions
Alumis (NASDAQ: ALMS) and ACELYRIN have finalized an amended merger agreement. Under the revised terms, ACELYRIN stockholders will receive 0.4814 Alumis shares per share held, achieving a pro forma cash position of about $737 million as of December 31, 2024. Full details are in the release.
Aerovate Therapeutics (AVTE) confirmed that stockholders approved its merger with Jade Biosciences along with a 1-for-35 reverse stock split and a special cash dividend of $69.6 million for record shareholders. The combined entity will trade as Jade Biosciences (JBIO) on Nasdaq. More is detailed in the announcement.
TPG and Temasek have joined TA Associates in a significant minority investment in Cliffwater, a private markets funds leader managing around $36 billion in AUM. The transaction, expected to close in Q2 2025, enables Cliffwater’s management to retain majority control. Discover further details in the announcement.
Healthcare Services & Corporate Transactions
Concentra (NYSE: CON), the largest U.S. occupational health services provider, has signed a definitive agreement to acquire Pivot Onsite Innovations from Athletico Physical Therapy for $55 million. The acquisition, which will double Concentra’s onsite network across 40+ states, brings expanded service offerings and enhanced community health engagement. More details are available in the announcement.
Consumer & Corporate Strategy Updates
Chipotle Mexican Grill (NYSE: CMG) signed a development agreement with Alsea for its inaugural foray into the Mexican market, a key milestone in its international expansion strategy. The first restaurant is slated to open by early 2026. Read the detailed update.
MySize (NASDAQ: MYSZ) shared a robust strategic outlook for 2025 with an 18% revenue growth in 2024, doubled cash reserves, and a 37% reduction in net loss. Two signed LOIs for potential acquisitions and ongoing integrations highlight its AI-powered retail optimization strategy. More details can be found in the CEO letter.
Automotive & Mobility Innovations
BorgWarner (BWA) is set to showcase its latest electric commercial vehicle technology at the Advanced Clean Transportation Expo 2025 in Anaheim. Its innovative iM-575 integrated inverter-motor drive module delivers 1,829 Nm of peak torque and 412 kW of continuous power for Class 6 to 8 vehicles. Additional solutions will be on display. Read more in the announcement.
Defense & Security Updates
Silynxcom (NYSE American: SYNX) has received roughly $10 million in orders from the Israel Defense Forces since October 2023. These orders for in-ear headset solutions and tactical communication accessories are designed to enhance durability and situational awareness across diverse operational settings. More details are available in the update.
Banking & Financial Services
Associated Banc-Corp (NYSE: ASB) opened its first Missouri branch in St. Louis at Dellwood Crossing Shopping Center. The new 6,000-square-foot facility, which includes a Community Advocacy Center and meeting space, marks a strategic market expansion and aims to offer first-time home buyer education, financial literacy programs, and fraud prevention classes. More details are in the announcement.
Metropolitan Bank Holding Corp. (NYSE: MCB) reported strong Q1 2025 results with net income of $16.4 million (or $1.45 per diluted share), total loans of $6.3 billion (up 5.1% from Q4 2024), and deposits of $6.4 billion (a 7.8% increase). The bank’s net interest margin improved to 3.68%, and it repurchased $12.9 million of common stock. Full details are in the release.
Compliance & Regulatory Developments
Village Farms International (VFF) has been granted a 180-day extension by Nasdaq to meet the minimum bid price requirement of US$1.00 per share. The extension, which now runs until October 13, 2025, gives the company additional time to achieve compliance before facing potential delisting. Read more in the announcement.
